Clinical Trial Update: Efficacy and Safety of T+A+RAD in HCC [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update on efficacy and safety of T+A+RAD in hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• T+A+RAD

Snippet

Sponsor: Fudan University | Conditions: Hepatocellular Carcinoma | Phase 2 | Status: UNKNOWN